Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
152 hedge funds and large institutions have $398M invested in Sciclone Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 21 closing their positions.
54% more call options, than puts
Call options by funds: $210K | Put options by funds: $136K
35% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 46
5% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 21
1% more funds holding
Funds holding: 151 → 152 (+1)
23% less capital invested
Capital invested by funds: $520M → $398M (-$121M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$22.7M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.86M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$3.46M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.93M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$2.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$35.4M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$14.1M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$8.04M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.87M |
| 5 |
SI
Sensato Investors
San Francisco,
California
|
-$3.13M |
SCLN Hedge Fund Activity: Q3 2016 in Review
152 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2016, worth a combined $398M — down 23% from $520M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SCLN positions and 21 closed out — a net gain of 1 holder — while 62 added to existing stakes and 46 trimmed.
The largest buyer was Numeric Investors, adding an estimated $22.7M. The largest seller was Franklin Resources, cutting an estimated $35.4M.
- 152 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2016, up from 151 in Q2 2016.
- Funds reported $398M of Sciclone Pharmaceuticals Inc stock for Q3 2016, down 23% quarter-over-quarter.
- 22 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2016 and 21 closed out, a net change of +1 holder.
- The largest Sciclone Pharmaceuticals Inc buyer in Q3 2016 was Numeric Investors, an estimated $22.7M added.
- The largest Sciclone Pharmaceuticals Inc seller in Q3 2016 was Franklin Resources, an estimated $35.4M sold.
Based on aggregated 13F filings for Q3 2016.